1
Clinical Trials associated with Anti-HBV therapy(Apeloa) / CompletedNot Applicable Observational, Post-marketing Renal Safety Surveillance Registry in Subjects With Chronic Hepatitis B (HBV) Infection With Decompensated Liver Disease Receiving Nucleotide/Side Therapy
This registry will remain open for approximately 5 years (4 years of enrollment + 1 year of follow up). Subjects will be followed until Orthotopic Liver Transplant (OLT), resolution of liver decompensation, death, or conclusion of the registry.
100 Clinical Results associated with Anti-HBV therapy(Apeloa)
100 Translational Medicine associated with Anti-HBV therapy(Apeloa)
100 Patents (Medical) associated with Anti-HBV therapy(Apeloa)
100 Deals associated with Anti-HBV therapy(Apeloa)